戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  treatment of symptomatic refractory hepatic hydrothorax.
2 patients with symptomatic refractory hepatic hydrothorax.
3 anagement of symptomatic, refractory hepatic hydrothorax.
4  hepatopulmonary syndrome, POPH, and hepatic hydrothorax.
5 topulmonary hypertension (POPH), and hepatic hydrothorax.
6 patient (0.7%) developed a pneumothorax with hydrothorax after CVC placement for PBSC collection.
7 a 53-year-old man who presented with hepatic hydrothorax and ascites, whose workup revealed cirrhosis
8  malignancy and predict tumor origin in both hydrothorax and ascites.
9 ice, as demonstrated by cardiac hypertrophy, hydrothorax, and ascites.
10  of refractory cirrhotic ascites and hepatic hydrothorax, and treatment of hepatorenal failure and he
11  (18.3% vs. 33.9%, P = 0.004) and refractory hydrothorax/ascites (6.9% vs. 16.5%, P = 0.019) in the e
12 nts with decompensated cirrhosis and hepatic hydrothorax have higher risk of sepsis following endosco
13  nodules, interstitial lung disease, hepatic hydrothorax, hepatopulmonary syndrome, and portopulmonar
14  of its complications (hyponatremia, hepatic hydrothorax), hepatorenal syndrome, spontaneous bacteria
15 topulmonary hypertension (POPH), and hepatic hydrothorax (HH).
16                                      Hepatic hydrothorax is a rare complication of portal hypertensio
17  with cirrhosis with ascites in whom hepatic hydrothorax is identified.
18 apy may be successful but refractory hepatic hydrothorax is not uncommon.
19 control of the refractory ascites or hepatic hydrothorax is required.
20                     Management of refractory hydrothorax is usually ineffective and can result in a w
21 ents, antibiotic prophylaxis and drainage of hydrothorax may be required to prevent sepsis before ele
22  portosystemic shunt (TIPS)], but refractory hydrothorax may require other interventions.
23 re given routinely, and all cases of hepatic hydrothorax (n = 10) were drained.
24  = 14), acute variceal bleeding (n = 3), and hydrothorax (n = 2).
25 1.7; 95% CI: 1.04, 2.7; P = .03) and hepatic hydrothorax (odds ratio, 2.2; 95% CI: 1.1, 4.2; P = .02)
26 13.95 and 3.97-50.23, respectively), hepatic hydrothorax (OR 4.85; 95% CI 1.37-17.20), and use of ant
27 atients with cirrhosis with ascites, hepatic hydrothorax, or volume overload should be managed with d
28                                      Hepatic hydrothorax requires similar therapy to ascites [repeate
29                                      Hepatic hydrothorax results from the passage of ascites across t
30                  Although refractory hepatic hydrothorax (RH) is a serious complication of cirrhosis,
31 ients with refractory ascites and/or hepatic hydrothorax should be considered for liver transplantati
32 PRACTICE ADVICE 5: Refractory ascites and/or hydrothorax should be managed with therapeutic paracente
33 9 for refractory ascites, and 24 for hepatic hydrothorax (total, 129).
34 ations other than refractory ascites/hepatic hydrothorax, vascular liver disease, HCC, or insufficien
35  (BPA) on the management of ascites, hepatic hydrothorax, volume overload, and hyponatremia in patien
36 ed patients with refractory ascites, hepatic hydrothorax, volume overload, or hyponatremia should be
37 EST PRACTICE ADVICE 3: Patients with hepatic hydrothorax with dyspnea and/or hypoxemia should undergo